The new generation of GABA enhancers. Potential in the treatment of epilepsy.
about
Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channelsTopiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking.PHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLDThe role of glutamate in anxiety and related disorders.Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients.Topiramate in the prophylactic treatment of cluster headache.Pregabalin: a new anxiolytic.The role of GABA(A) receptors in the development of alcoholismGABA-ergic drugs: exit stage left, enter stage right.Clinical utility of adjunctive retigabine in partial onset seizures in adults.Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study.Therapeutic drug monitoring of old and newer anti-epileptic drugs.Progress in neuroprotective strategies for preventing epilepsy.Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity.GABA(A) receptors in normal development and seizures: friends or foes?Effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on the protective action of various antiepileptic drugs in the maximal electroshock-induced seizure model: a type II isobolographic analysis.The challenge of pain management in patients with myasthenia gravis.Soybean greatly reduces valproic acid plasma concentrations: a food-drug interaction studyVigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval.GABAergic drugs in the treatment of epilepsy: modern or outmoded?GABA transporters as targets for new drugs.Emerging drugs for focal epilepsy.Investigating psychotropic properties of antiepileptic drugs.Novel approaches to anticonvulsant drug discovery.Exploring the latest avenues for antiepileptic drug discovery and development.A meta-analysis of the efficacy of pregabalin in the treatment of generalized anxiety disorder.Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models.Mexiletine and its Interactions with Classical Antiepileptic Drugs: An Isobolographic Analysis.Homeostasis of brain dynamics in epilepsy: a feedback control systems perspective of seizures.Topiramate selectively attenuates nicotine-induced increases in monoamine release.Trichosanthes tricuspidata modulates oxidative toxicity in brain hippocampus against pilocarpine induced status epilepticus in mice.Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice.Ultrastructure of astrocytes in the cortex of the hippocampal gyrus and in the neocortex of the temporal lobe in experimental valproate encephalopathy and after valproate withdrawal.Effect of the administration of tiagabine and gabapentin on rabbit electroencephalogram activity.Effects of low-frequency hippocampal stimulation on gamma-amino butyric acid type B receptor expression in pharmacoresistant amygdaloid kindling epileptic rats.Involvement of GABAergic and glutamatergic systems in the anticonvulsant activity of 3-alkynyl selenophene in 21 day-old rats.Loss of hippocampal interneurons and epileptogenesis: a comparison of two animal models of acquired epilepsy.Hippocampal low-frequency stimulation inhibits afterdischarge and increases GABA (A) receptor expression in amygdala-kindled pharmacoresistant epileptic rats.Valproic acid reduces neuritic plaque formation and improves learning deficits in APP(Swe) /PS1(A246E) transgenic mice via preventing the prenatal hypoxia-induced down-regulation of neprilysin.
P2860
Q24632593-A8C29C0A-F3BF-4970-962E-1F8C879DD4F2Q28237504-821F2BFA-9401-4BD8-8081-25E419167F18Q30413247-1F374B9B-17C0-4141-B2E7-25873DE4CD39Q30474822-A7F607BC-1A2B-49C1-AF9B-D600F01E6124Q31029023-DA660B6A-DB86-4169-8128-FF13BC1C2057Q33868103-8893B645-74ED-405A-A9F5-5C669ADE3CD2Q33967443-8C35CB50-55F0-40C5-BC96-B39BF90FB23CQ34187006-D6E60329-7932-40EF-9A06-100F203C6981Q34774410-E1D26726-CC56-4366-9A51-0AEBD0DC19E9Q35180791-8786A3EE-8599-4F86-BE2C-58C7AFF9A604Q35717049-917F47A5-C6B3-49CF-95A7-3E082B848EBDQ35866260-B11C500B-1C87-42ED-9E7A-AEAD0A74EC23Q35970354-2C140F2B-922C-4FD8-A890-FAA8A82B13C4Q36739694-9C649105-6DCF-4574-8D2B-18208102DB7DQ36999739-7CA8DD2C-B514-4E70-8277-625F0A3E4230Q37104140-9F30365E-2A3E-4687-BE7F-047FFC18239BQ37325722-16720CD7-7D42-4955-83EE-3BA9C761400AQ37577775-BFBF11FE-749A-43DC-9150-57FE8A9A9826Q37631643-02BC8126-86DA-4351-9034-323527832E28Q37642768-13E6BBC6-1012-4B3C-8C40-69BB24F4FEC4Q37856281-FB7DF945-2915-4368-B62F-16797A4E6307Q37856289-C5E01B84-EA14-4B51-956B-3F5DBBEA855EQ38062011-A6784B6E-6FFE-40CE-AA92-F071AC104463Q38112212-8DB108DC-EAF8-46CD-94DC-F9F355F4D950Q38139499-5EEABEA0-B346-4E12-B408-5A6D89B58D13Q38754189-F3584967-36BD-40C0-9AC5-9EE488208563Q39702488-341893E4-4E97-49F3-B603-7471DA6F79B4Q39924456-89AF029E-4F04-48FF-BDE7-B84FA0454ECDQ40135610-571C9FC1-224C-41AB-8A37-E675CCBA2073Q42769314-BCC5D20E-C60D-4305-9C9C-575B7B4C940CQ43825597-F0D3B58E-BE6F-4B3F-841B-316EA47B3D69Q44122594-0BBA7EA0-76BA-4A65-8622-63EE402483DDQ44515038-F7EB9452-505A-4329-93A7-152CF1894407Q44585274-D5E598CD-0C7C-455D-AB71-8DAA1BA8DB84Q48398770-F4271722-214F-4A39-A7F1-0024F22CB3E8Q48413614-0597C00B-C358-4186-8008-088E99A3B842Q48650701-32C6CB3F-F747-4426-A278-549CD294AEC6Q48956310-63F048F0-21AB-428A-972C-3CD9F47E27BCQ50649503-8EB86D40-9F99-4C1C-B072-56B338B1AE54Q50706209-35822C58-2B56-4B4B-8003-24958145ADC5
P2860
The new generation of GABA enhancers. Potential in the treatment of epilepsy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
The new generation of GABA enhancers. Potential in the treatment of epilepsy.
@ast
The new generation of GABA enhancers. Potential in the treatment of epilepsy.
@en
The new generation of GABA enhancers. Potential in the treatment of epilepsy.
@nl
type
label
The new generation of GABA enhancers. Potential in the treatment of epilepsy.
@ast
The new generation of GABA enhancers. Potential in the treatment of epilepsy.
@en
The new generation of GABA enhancers. Potential in the treatment of epilepsy.
@nl
prefLabel
The new generation of GABA enhancers. Potential in the treatment of epilepsy.
@ast
The new generation of GABA enhancers. Potential in the treatment of epilepsy.
@en
The new generation of GABA enhancers. Potential in the treatment of epilepsy.
@nl
P1433
P1476
The new generation of GABA enhancers. Potential in the treatment of epilepsy.
@en
P2093
Czuczwar SJ
Patsalos PN
P304
P356
10.2165/00023210-200115050-00001
P577
2001-01-01T00:00:00Z
P5875
P6179
1007231758